DIVISION OF CARDIOLOGY - SUMMARY OF WEEKLY ROUNDS SCHEDULE
MONDAY, JANUARY 18 to FRIDAY, JANUARY 22, 2016
Monday, January 18:
8:00-9:00
12:00-1:30
Aud B UH,
B2-116 VH &
B2-075
St. Joseph’s
OTN Event #
50409512
B6-115 UH
OTN Event #
50896982
Cardiovascular Grand Rounds Presenter: J. Roberts
Title of Presentation: Arrhythmia Genetics: Clinical Implications for Common and Rare Diseases
Learning Objectives:
1. Atrial fibrillation has an underlying genetic contribution that may be clinically actionable.
2. Gene-environment interactions may play a critical role in disease development.
3. Bundle branch reentrant tachycardia may have an underlying genetic etiology.
Adult Congenital Cardiac Surgery Rounds - Videoconference from Toronto
Cases & Learning Objectives:
Case 1 – Dr. Oechslin Dx: Ross procedure for severe BAV stenosis: severe neo-aortic valve regurgitation. Pulmonary
hypertension. To review cath, echo and MRI. Management planning.
Case 2 – Dr. Oechslin Dx: Repaired TOF, PVR. Severe TR. Severely dilated right ventricle with severe systolic dysfunction.
To review cath, echo and MRI. Management planning.
Case 3 – Dr. Oechslin Dx: Unrepaired cyanotic congenital heart disease. Congenitally corrected transposition of the great
arteries (ccTGA). Non-restrictive VSD. Right ventricular outflow tract obstruction. To review echo, MRI and CP study.
Conservative management vs surgical repair.
Case 4 – Dr. Roche Dx: Repaired coarctation with left subclavian flap. Bicuspid aortic valve post balloon valvuloplasty. Severe
aortic regurgitation. Mildly dilated proximal ascending aorta. To review cath and MRI. Surgical referral.
Tuesday, January 19:
7:00-8:00
B6-115 UH
OTN Event #
51364996
Complex Revascularization Rounds Presenters: CV Surgeons & Interventional Cardiologists
Faculty Supervisors: D. Nagpal & P. Garg
Case-based presentation and discussion
Learning Objectives:
1. To develop a systematic approach to interpretation of coronary angiograms.
2. To discuss interesting case examples and their management.
3. To apply an evidence-based approach to complex revascularization cases in order to improve outcomes.
2:00-5:00
2:00-5:00
B6-128 UH
B6-128 UH
DIDACTIC EDUCATION SESSIONS:
COMMUNICATIONS SEMINAR
Presenter: A. Foat
Topic: The Role Social Media is Playing in Medicine & Personal Branding
Learning Objectives:
1. Overview the impact of digital in medicine.
2. How digital is transforming medicine.
3. Leveraging digital to raise personal brand.
Wednesday, January 20:
8:00-9:00
12:00-1:00
B6-115 UH
EP Rounds: Device Rounds Presenters: Attendings & Fellows
Learning Objectives:
OTN Event #
50200630
1. To develop a systematic approach to device tracings.
2. To discuss interesting case examples.
3. To review programming features and troubleshooting.
B6-115 UH &
C2-504 VH
Adult Congenital Cardiac Teaching Rounds - Videoconference from Toronto
Presenter: I. Uribe-Morales Supervisor: A. Kovacs
Title of Presentation: Anticoagulation in Adults with Congenital Heart disease. Is there any room
for improvement?
OTN Event #
46453499
Thursday, January 21:
7:00-8:00
8:00-9:00
B6-115 UH &
B2-122 VH
Cardiac Cath/Interventional Rounds Presenter: P. Teefy
Title of Presentation: Hybrid Coronary Revascularization: Where are we in 2016?
Learning Objectives:
OTN Event#
47771990
1.
2.
3.
4.
5.
B6-128 UH
Graphics Rounds: Ambulatory Monitors Presenter: L. Gula
Define HCR and various options/protocols.
Review rationale for HCR.
Discuss advantages and disadvantages of the technique.
Review case studies to illustrate technical issues/optimal anatomy and pitfalls.
Discuss need for ongoing study of this mode of revascularization.
Friday, January 22:
8:00-9:00
B6-128 UH
EP Tracing Rounds: Case Presentations with ECG and Intra-cardiac tracings
Presenters: Attendings & Fellows
Learning Objectives:
1. To develop a systematic approach to EP tracings.
2. To discuss interesting case examples.
3. To review electrophysiology principles and concepts.
Some of these educational activities/rounds are an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal
College of Physicians and Surgeons of Canada, approved by the Division of Cardiology Education Committee - Western University.
Supported by unrestricted grants-in-aid provided by:
Aegerion Pharmaceuticals (Juxtapid (lomitapide)), Amgen Canada Inc. (Repatha), AstraZeneca Canada Inc. (Brilinta (Ticagrelor)),
Bayer HealthCare Pharmaceuticals (XARELTO® rivaroxaban tablet), Boehringer Ingelheim (Canada) Ltd. (Pradax (dabigatran), Twynsta (telmisartan/amlodipine)),
Bristol-Myers Squibb Canada & Pfizer Canada Inc., (Eliquis (apixaban)), Medtronic of Canada Inc., Merck (Ezetrol, Olmetec®), Novartis Pharmaceuticals of
Canada Inc. (Entresto), Servier Canada Inc. (Coversyl)